Figures computed from official regulatory filings — .
Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Bellerophon Therapeutics, Inc.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | Cluster | SEC | |
Bellerophon Therapeutics, Inc.Listing unverified | Buy | n/a (No price was disclosed in the filing) | conv 71ClusterFirst in 12mo | SEC | |
Bellerophon Therapeutics, Inc.Listing unverified | BuyD (derivative) | n/a (No price was disclosed in the filing) | ClusterFirst in 12mo | SEC | |
Bellerophon Therapeutics, Inc.Listing unverified | Buy | n/a (No price was disclosed in the filing) | conv 60Cluster | SEC | |
Bellerophon Therapeutics, Inc.Listing unverified | Buy | $4.3M | conv 53ClusterFirst in 12mo | SEC |